Cargando…

Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study

BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wen-qiang, Li, Jian, Liang, Bin-yong, Lv, Xing, Zhu, Rong-hua, Wang, Jin-lin, Huang, Zhi-yong, Yang, Shu-hong, Zhang, Er-lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433922/
https://www.ncbi.nlm.nih.gov/pubmed/36059669
http://dx.doi.org/10.3389/fonc.2022.980736
_version_ 1784780742396477440
author Wang, Wen-qiang
Li, Jian
Liang, Bin-yong
Lv, Xing
Zhu, Rong-hua
Wang, Jin-lin
Huang, Zhi-yong
Yang, Shu-hong
Zhang, Er-lei
author_facet Wang, Wen-qiang
Li, Jian
Liang, Bin-yong
Lv, Xing
Zhu, Rong-hua
Wang, Jin-lin
Huang, Zhi-yong
Yang, Shu-hong
Zhang, Er-lei
author_sort Wang, Wen-qiang
collection PubMed
description BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed with pathology-confirmed cHCC-CCA, and who underwent curative resection at Tongji hospital between January 2010 and December 2019 were included in this retrospective study. A one-to-one propensity score matching (PSM) analysis was used to compare the long-term outcomes of AR to those of NAR. RESULTS: A total of 105 patients were analyzed, of whom 48 (45.7%) and 57 (54.3%) underwent AR and NAR, respectively. There were no significant differences in short-term outcomes between the two groups, including duration of postoperative hospital stay, the incidence of perioperative complications, and incidence of 30-day mortality. However, both, the 5-year overall survival (OS) and recurrence-free survival (RFS) rates of AR were significantly better than those of NAR (40.5% vs. 22.4%, P=0.002; and 37.3% vs. 14.4%, P=0.002, respectively). Multivariate analysis showed that NAR, multiple tumors, larger-sized tumors (>5 cm), cirrhosis, lymph node metastasis, and vascular invasion were independent risk factors for poor prognoses. Stratified analysis demonstrated similar outcomes following AR versus NAR for patients with tumors > 5cm in diameter, while AR had better survival than NAR in patients with tumors ≤5 cm in diameter. After PSM, when 34 patients from each group were matched, the 5-year OS and RFS rates of AR were still better than those of NAR. CONCLUSION: Patients with cHCC-CCA who underwent AR had better long-term surgical outcomes than those who underwent NAR, especially for those with tumors ≤5 cm in diameter. However, no differences in the risk of surgical complications were detected between the two groups.
format Online
Article
Text
id pubmed-9433922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94339222022-09-02 Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study Wang, Wen-qiang Li, Jian Liang, Bin-yong Lv, Xing Zhu, Rong-hua Wang, Jin-lin Huang, Zhi-yong Yang, Shu-hong Zhang, Er-lei Front Oncol Oncology BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed with pathology-confirmed cHCC-CCA, and who underwent curative resection at Tongji hospital between January 2010 and December 2019 were included in this retrospective study. A one-to-one propensity score matching (PSM) analysis was used to compare the long-term outcomes of AR to those of NAR. RESULTS: A total of 105 patients were analyzed, of whom 48 (45.7%) and 57 (54.3%) underwent AR and NAR, respectively. There were no significant differences in short-term outcomes between the two groups, including duration of postoperative hospital stay, the incidence of perioperative complications, and incidence of 30-day mortality. However, both, the 5-year overall survival (OS) and recurrence-free survival (RFS) rates of AR were significantly better than those of NAR (40.5% vs. 22.4%, P=0.002; and 37.3% vs. 14.4%, P=0.002, respectively). Multivariate analysis showed that NAR, multiple tumors, larger-sized tumors (>5 cm), cirrhosis, lymph node metastasis, and vascular invasion were independent risk factors for poor prognoses. Stratified analysis demonstrated similar outcomes following AR versus NAR for patients with tumors > 5cm in diameter, while AR had better survival than NAR in patients with tumors ≤5 cm in diameter. After PSM, when 34 patients from each group were matched, the 5-year OS and RFS rates of AR were still better than those of NAR. CONCLUSION: Patients with cHCC-CCA who underwent AR had better long-term surgical outcomes than those who underwent NAR, especially for those with tumors ≤5 cm in diameter. However, no differences in the risk of surgical complications were detected between the two groups. Frontiers Media S.A. 2022-08-18 /pmc/articles/PMC9433922/ /pubmed/36059669 http://dx.doi.org/10.3389/fonc.2022.980736 Text en Copyright © 2022 Wang, Li, Liang, Lv, Zhu, Wang, Huang, Yang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wang, Wen-qiang
Li, Jian
Liang, Bin-yong
Lv, Xing
Zhu, Rong-hua
Wang, Jin-lin
Huang, Zhi-yong
Yang, Shu-hong
Zhang, Er-lei
Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title_full Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title_fullStr Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title_full_unstemmed Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title_short Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
title_sort anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: a propensity score matched study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433922/
https://www.ncbi.nlm.nih.gov/pubmed/36059669
http://dx.doi.org/10.3389/fonc.2022.980736
work_keys_str_mv AT wangwenqiang anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT lijian anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT liangbinyong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT lvxing anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT zhuronghua anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT wangjinlin anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT huangzhiyong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT yangshuhong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy
AT zhangerlei anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy